Landauer — Q2 FY2012 Earnings Presentation
10 slides from Landauer's earnings presentation, May 8, 2012
Slide 1: Fiscal 2012 Second Quarter Results
LANDAUER, INC. Fiscal 2012 Second Quarter Results May 8, 2012
Slide 2: Safe Harbor Statement
This presentation may contain forward - looking statements, including statements about the outlook and prospects for Company and industry growth, as well as statements about the Company’s future financial and operating performance . Some of the information shared here constitutes forward - looking s
Slide 3: Fiscal 2012 Second Quarter Highlights
3 Revenue grew 21 percent to $39.1 million Gross profit grew 11 percent to $ 23.1 million on increased revenue and improved business mix The US military continued to expand relationship with Landauer, generating international military interest Medical Products segment contributed $4.0 millio
Slide 4: Landauer Strategy Overview
Value Creation Deliver Upside Growth 1. Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic Expansion Optimize the Core Competitive Growth New Management in 2006 ― New CFO in 1Q’12 Restructure: Cost IT/ERP system upgrades OSL /
Slide 5: The Radiation Safety Continuum
Therapeutic / Diagnostic Accessories Information Imaging Physics Therapy Physics Patient Monitoring Occupational Monitoring Consulting Strategic Expansion Existing Services with Penetration Opportunities* Complementary Adjacent Products / Services _____________________ (1) Average Revenue per Facili
Slide 6: Addressable Markets
Addressable Markets 2005 2010 2011 2012 Occupational Monitoring Radon Military Emergency Response Forensics Dose Reconstruction Patient Dose Consumer Radiation Radiation Markers Radiation Shielding Occupation Monitoring Radiation Instruments Radiation Measurements Patient Dose Information Management
Slide 7: Competitive Growth: Expanding Global Military Relationships
7 Competitive Growth Expanding Global Military Relationships The U.S. military has now issued orders in excess of $17 million to upgrade the Army’s tactical dosimetry capabilities, and dosimetry laboratory • Substantially completed first article testing and plan to begin Radwatch system shipments
Slide 8: Strategic Expansion: Medical Physics and Medical Products
8 Strategic Expansion Medical Physics Medical Physics produced $7.7 million in revenues for second quarter 2012; represents growth of over 60% from prior year period Results highlight ongoing efforts to increase episodic equipment commissioning sales leveraging a relatively fixed cost structure
Slide 9: Optimize the Core: Systems Initiative Update
9 Optimize the Core Systems Initiative Update On schedule to support “Go - Live” of the final phase of the project in fiscal 2012 in July 2012 – Meetings with 150 key customers accounts in the quarter to overview system benefits Substantial expense will be incurred to support the successful laun
Slide 10: Dividend Policy and Outlook
Dividend Policy and Outlook 10 Dividend Policy Board of Directors declared a regular quarterly cash dividend of $0.55 per share for the second quarter of fiscal 2012 – This represents an annual rate of $2.20 per share, consistent with fiscal 2011 levels – The dividend was paid on April 3, 2012 to